Search Form

Equity

IHE

iShares U.S. Pharmaceuticals ETF

Overview

Loading

Performance

Performance

  • Returns

  1y 3y 5y 10y Incept.
-15.53 14.87 16.26 13.13 12.64
Market Price (%) Market price return represents changes to the midpoint price and accounts for distributions from the fund. The midpoint is the average of the bid-ask prices at 4:00 PM ET (when NAV is normally determined for most funds). -15.52 14.85 16.25 13.13 12.64
Benchmark (%) Index: Dow Jones U.S. Select Pharmaceuticals Index -15.29 15.24 16.68 13.61 13.13
After Tax Pre-Liq. (%) Return after taxes on distributions. Assumes fund shares have not been sold. -15.93 14.49 15.90 12.84 12.35
After Tax Post-Liq. (%) Return after taxes on distributions and sale of fund shares. -8.42 11.68 13.16 11.01 10.58
  YTD 1m 3m 6m 1y 3y 5y 10y Incept.
-10.04 -1.03 5.77 -10.04 -15.53 51.57 112.39 243.39 235.48
Market Price (%) Market price return represents changes to the midpoint price and accounts for distributions from the fund. The midpoint is the average of the bid-ask prices at 4:00 PM ET (when NAV is normally determined for most funds). -10.07 -1.10 5.79 -10.07 -15.52 51.47 112.34 243.41 235.36
Benchmark (%) Index: Dow Jones U.S. Select Pharmaceuticals Index -9.85 -1.01 5.92 -9.85 -15.29 53.02 116.22 258.36 250.33
After Tax Pre-Liq. (%) Return after taxes on distributions. Assumes fund shares have not been sold. -10.14 -1.08 5.72 -10.14 -15.93 50.06 109.13 234.63 226.80
After Tax Post-Liq. (%) Return after taxes on distributions and sale of fund shares. -5.61 -0.54 3.32 -5.61 -8.42 39.29 85.51 184.10 178.06

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.

Growth of Hypothetical $10,000 The growth of hypothetical $10,000 chart reflects a hypothetical $10,000 investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted.

Performance chart data not available for display.
View full chart

Distributions

Ex-Date Total Distribution Income
View full table

Premium/Discount

Key Facts

Key Facts

Net Assets as of 22-Jul-2016 $643,872,333
Inception Date 01-May-2006
Exchange NYSE Arca
Asset Class Equity
Benchmark Index Dow Jones U.S. Select Pharmaceuticals Index
Index Ticker DJSPHMT
Shares Outstanding as of 22-Jul-2016 4,200,000
CUSIP 464288836
Options Available Yes

Portfolio Characteristics

Portfolio Characteristics

This information must be preceded or accompanied by a current prospectus. For standardized performance, please see the Performance section above.

Fees

Fees

Holdings

Holdings

as of 21-Jul-2016
Ticker Name Sector Shares Market Value Weight (%) Price Exchange Notional Value
JNJ JOHNSON & JOHNSON Health Care 520,950 $65,196,893 10.14 125.15 New York Stock Exchange Inc. 65,196,892.50
PFE PFIZER INC Health Care 1,488,467 $54,641,624 8.50 36.71 New York Stock Exchange Inc. 54,641,623.57
MRK MERCK & CO INC Health Care 821,852 $48,316,679 7.51 58.79 New York Stock Exchange Inc. 48,316,679.08
BMY BRISTOL MYERS SQUIBB Health Care 588,239 $44,412,045 6.90 75.50 New York Stock Exchange Inc. 44,412,044.50
AGN ALLERGAN Health Care 160,260 $39,718,838 6.18 247.84 New York Stock Exchange Inc. 39,718,838.40
LLY ELI LILLY Health Care 480,334 $38,618,854 6.00 80.40 New York Stock Exchange Inc. 38,618,853.60
ZTS ZOETIS INC CLASS A Health Care 489,528 $24,544,934 3.82 50.14 New York Stock Exchange Inc. 24,544,933.92
MYL MYLAN NV Health Care 491,100 $23,012,946 3.58 46.86 NASDAQ 23,012,946.00
TSRO TESARO INC Health Care 220,926 $20,334,029 3.16 92.04 NASDAQ 20,334,029.04
PRGO PERRIGO PLC Health Care 203,292 $18,605,284 2.89 91.52 New York Stock Exchange Inc. 18,605,283.84
Ticker Name Asset Class Weight (%) Price Shares Market Value Notional Value Sector SEDOL ISIN Exchange
Holdings are subject to change.

Exposure Breakdowns

Exposure Breakdowns

as of 21-Jul-2016

% of Market Value

Allocations are subject to change.

Literature

Literature

 

How to Buy

How to Buy

There are many ways to access iShares Funds. Learn how you can add them to your portfolio.